Heptakis(2,6-di-O-methyl-3-O-acetyl)-β-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity

Journal of Pharmaceutical Sciences

Volumn 88, Issue 10, 1999, Pages 970-975

  Hirayama, Fumitoshi ^a   Mieda, Shiuhei ^a   Miyamoto, Yuji ^a   Arima, Hidetoshi ^a   Uekama, Kaneto ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; FLURBIPROFEN; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG SOLUBILITY; HEMOLYSIS; HYDROLYSIS; HYDROPHOBICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MASS SPECTROMETRY; MUSCLE NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RABBIT; SURFACE TENSION;

EID: 0032836921     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js990128i     Document Type: Article

References (34)

1. Duchêne, D., Ed. Cyclodextrin and Their Industrial Uses; Editions de Santé: Paris, 1987.
2. Uekama, K.; Otagiri, M. Cyclodextrins in drug carrier systems. CRC Crit. Rev. Ther. Drug Carrier Syst. 1987, 3, 1-40.
3. Szejtli, J., Ed. Cyclodextrin Technology; Kluwer: Dordrecht, 1988.
4. Loftsson, T.; Brewster, M. E. Pharmaceutical applications of cyclodextrins. Drug solubilization and stabilization. J. Pharm. Sci. 1996, 85, 1017-1025.
5. Stella, V. J.; Rajewski, R. A. Cyclodextrins: Their future in drug formulation and delivery. Pharm. Res. 1997, 14, 556-567
6. Uekama, K.; Hirayama, F.; Irie, T. Cyclodextrin drug carrier systems. Chem. Rev. 1998, 98, 2045-2076.
7. Pitha, J.; Szente, L.; Szejtli, J. Molecular encapsulation of drugs by cyclodextrins and congeners. In Controlled Drug Delivery; Bruck, S. D., Ed.; CRC: Boca Raton, FL, 1983; pp 125-148.
8. Albers, E.; Müller, B. W. Cyclodextrin derivatives in pharmaceutics. CRC Crit. Rev. Ther. Drug Carrier Syst. 1995, 12, 311-337.
9. Duchêne, D.; Ponchel, G.; Wouessidjewe, D. Cyclodextrins in targeting. Application to nanoparticles. Adv. Drug Delivery Rev. 1999, 36, 29-40.
10. Hirayama, F.; Uekama, K. Cyclodextrin-based controlled drug release. Adv. Drug Delivery Rev. 1999, 36, 125-141.
11. Hermens, W. A. J. J.; Deurloo, M. J. M.; Romeyn, S. G.; Verhoef, J. C.; Merkus, F. W. H. M. Nasal absorption enhancement of 17β-estradiol by diemthyl-β-cyclodextrin in rabbits and rats. Pharm. Res. 1990, 7, 500-503.
12. Pitha, J. Enhanced water solubility of vitamins A, D, E, and K by substituted cycloamyloses. Life Sci. 1981, 29, 307-311.
13. Uekama, K.; Horiuchi, Y.; Kikuchi, M.; Hirayama, F. Enhanced dissolution and oral bioavailability of α-tocopheryl esters by dimethyl-β-cyclodextrin complexation. J. Incl. Phenom. 1988, 6, 167-174.
14. Miyake, K.; Hirayama, F.; Uekama, K. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-α-and -β-cyclodextrins in aqueous solution. J. Pharm. Sci. 1999, 88, 39-45.
15. L.-Nicolas, J. M.; Bru, R.; S.-Ferrer, A.; G.-Carmona, F. Use of soluble lipids for biochemical processes: Linoleic acid-cyclodextrin inclusion complexes in aqueous solutions. Biochem. J. 1995, 308, 151-154.
16. Irie, T.; Uekama, K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997, 86, 147-162.
17. Frank, D. W.; Gray, J. E.; Weaver, R. N. Cyclodextrin nephrosis in the rat. Am. J. Pathol. 1976, 83, 367-382.
18. 14C-β-cyclodextrin in rat. Arzneim. - Forsch. 1985, 35, 1042-1047.
19. Yamamoto, N.; Yoshida, A.; Hirayama, F.; Uekama, K. Some physicochemical properties of branched β-cyclodextrins and their inclusion characteristics. Int. J. Pharm. 1989, 49, 163-171.
20. Brewster, M. E.; Estes, K. S.; Bodor, N. An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys. Int. J. Pharm. 1990, 59, 231-243
21. Frijlink, H. W.; Visser, J.; Hefting, N. R.; Oosting, R.; Meijer, D. K. F.; Lerk, C. F. The pharmacokinetics of β-cyclodextrin and hydroxypropyl-β-cyclodextrin in the rat. Pharm. Res. 1990, 7, 1248-1252.
22. Shiotani, K.; Uehata, K.; Irie, T.; Uekama, K.; Thompson, D. O.; Stella, V. J. Differential effects of sulfate and sulfobutyl ether of β-cyclodextrin on erythrocyte membranes in vitro. Pharm. Res. 1995, 12, 78-84.
23. Thompson, D. O. Cyclodextrins - Enabling excipients: Their present and future use in pharmaceuticals. CRC Crit. Rev. Ther. Drug Carrier Syst. 1997, 14, 1-104.
24. Higuchi, T.; Connors, K. A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 1965, 4, 117-212.
25. Higuchi, T.; Kristiansen, H. Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies. J. Pharm. Sci. 1970, 59, 1601-1608.
26. Shintani, S.; Yamasaki, M.; Nakamura, M.; Nakayama, I. A new method to determine the irritation of drugs after intramuscular injection in rabbits. Toxicol. Appl. Pharmacol. 1967, 11, 293-301.
27. Imai, T.; Irie, T.; Otagiri, M.; Uekama, K. Comparative study on inclusion complexationa of antiinflammatory drug flurbiprofen with β-cyclodextrin and methylated β-cyclodextrins. J. Incl. Phenom. 1984, 2, 597-604.
28. Hansch, C.; Leo, A.; Unger, S. H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. Aromatic substituent constants for structure-activity correlations. J. Med. Chem. 1973, 16, 1207-1216.
29. Uekama, K.; Imai, T.; Maeda, T.; Irie, T.; Hirayama, F.; Otagiri, M. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-β-cyclodextrin. J. Pharm. Sci. 1985, 74, 841-845.
30. Harata, K. Induced circular dichroism of cycloamylose complexes with meta-and para-disubstituted benzenes. Bioorg. Chem. 1984, 10, 255-265.
31. Uekama, K.; Hirayama, F.; Imai, T.; Otagiri, M.; Harata, K. Crystal and molecular structure of 2: 2 (±)flurbiprofen-β-cyclodextrin complex. Chem. Pharm. Bull. 1983, 31, 3363-3365.
32. Harata, K.; Uekama, K.; Otagiri, M.; Hirayama, F. Conformation of permethylated cyclodextrins and the host-guest geometry of their inclusion complexes. J. Incl. Phenom. 1984, 1, 279-293.
33. Harata, K. Structural aspects of stereodifferentiation in the solid state. Chem. Rev. 1998, 98, 1803-1827.
34. Scott, R. L. Some comments on Benesi-Hildebrand equation-.Rec. Trav. Chim. 1958, 75, 787-789.